Search research articles
Contact Us
Filters
Showing results (201-210 of 241) with videos related to
Page
of 25
Sort By:
The Oncologist
|
December 8, 2020
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
James H Lewis, Hans Gelderblom, Michiel van de Sande, et al.
Pediatric Blood & Cancer
|
September 24, 2015
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
Cindy L Schwartz, Leonard H Wexler, Mark D Krailo, et al.
Acta Orthopaedica
|
May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
Michiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031
Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Nature Biomedical Engineering
|
July 15, 2020
Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer
Jiang Yang, Tai Wang, Lina Zhao, et al.
Journal of Surgical Oncology
|
February 9, 2019
Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma
Matthew T Houdek, Peter S Rose, Mario Hevesi, et al.
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
JCO Precision Oncology
|
August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
Koichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
Cancer Research
|
February 17, 2017
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles
Pasquale Sansone, Marjan Berishaj, Vinagolu K Rajasekhar, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 241) with videos related to
Sort By:
Page
of 25
The Oncologist
|
December 8, 2020
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
James H Lewis, Hans Gelderblom, Michiel van de Sande, et al.
Pediatric Blood & Cancer
|
September 24, 2015
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group
Cindy L Schwartz, Leonard H Wexler, Mark D Krailo, et al.
Acta Orthopaedica
|
May 12, 2021
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial
Michiel Van De Sande, William D Tap, Heather L Gelhorn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031
Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
Journal of Surgical Oncology
|
August 25, 2022
A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis
Nicholas M Bernthal, John H Healey, Emanuela Palmerini, et al.
Nature Biomedical Engineering
|
July 15, 2020
Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer
Jiang Yang, Tai Wang, Lina Zhao, et al.
Journal of Surgical Oncology
|
February 9, 2019
Low dose radiotherapy is associated with local complications but not disease control in sacral chordoma
Matthew T Houdek, Peter S Rose, Mario Hevesi, et al.
The Oncologist
|
July 4, 2025
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study
Andrew J Wagner, William D Tap, Sebastian Bauer, et al.
JCO Precision Oncology
|
August 11, 2022
Prospective Clinical Genomic Profiling of Ewing Sarcoma: <i>ERF</i> and <i>FGFR1</i> Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance
Koichi Ogura, Arielle Elkrief, Anita S Bowman, et al.
Cancer Research
|
February 17, 2017
Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles
Pasquale Sansone, Marjan Berishaj, Vinagolu K Rajasekhar, et al.
Page
of 25